Cooper Companies (COO) Cash & Equivalents (2009 - 2026)
Cooper Companies (COO) posted Cash & Equivalents of $138.8 million for Q2 2026, up 11.13% on a QoQ basis from $124.9 million in Q1 2026, and up 19.45% year-over-year from $116.2 million in Q2 2025.
Analysis
Cooper Companies (COO) Cash & Equivalents (2009 - 2026) Analysis & Trends
Cooper Companies has reported Cash & Equivalents for 18 years, with the latest figure at $138.8 million in Q2 2026.
- On a quarterly basis, Cash & Equivalents rose 19.45% year-over-year to $138.8 million in Q2 2026; TTM through Apr 2026 was $138.8 million, a 19.45% increase from a year earlier, with the FY2025 full-year figure at $110.6 million, up 2.79% from the prior year.
- Cash & Equivalents was $138.8 million for Q2 2026 at Cooper Companies, up from $124.9 million in the prior quarter.
- The five-year high for Cash & Equivalents was $399.2 million in Q2 2022, with the low at $100.9 million in Q1 2025.
- Average Cash & Equivalents over 5 years is $150.8 million, with a median of $119.5 million recorded in 2023.
- The sharpest annual moves came in 2022 and 2023: Cash & Equivalents soared 276.96% in 2022, then sank 71.97% in 2023.
- Over 5 years, Cash & Equivalents stood at $138.2 million in 2022, then decreased by 12.59% to $120.8 million in 2023, then fell by 10.93% to $107.6 million in 2024, then climbed by 2.79% to $110.6 million in 2025, then advanced by 25.5% to $138.8 million in 2026.
- The last three Cash & Equivalents figures came in at $138.8 million (Q2 2026), $124.9 million (Q1 2026), and $110.6 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 178.01 Bn | 172.41 Bn | 7.27 Bn | 5.10 Bn |
| 2 | Intuitive Surgical | 131.29 Bn | 126.08 Bn | 1.96 Bn | 2.76 Bn |
| 3 | Medtronic | 116.38 Bn | 107.56 Bn | 6.34 Bn | 1.69 Bn |
| 4 | Stryker | 106.01 Bn | 102.53 Bn | 4.50 Bn | 3.39 Bn |
| 5 | Boston Scientific | 63.40 Bn | 62.86 Bn | 3.85 Bn | 539.00 Mn |
| 6 | Edwards Lifesciences | 48.89 Bn | 44.64 Bn | 1.35 Bn | 2.91 Bn |
| 7 | Alcon | 32.59 Bn | 31.13 Bn | 1.68 Bn | 1.36 Bn |
| 8 | Dexcom | 31.84 Bn | 29.89 Bn | 830.00 Mn | 1.11 Bn |
| 9 | Steris | 20.61 Bn | 20.13 Bn | 684.20 Mn | 482.30 Mn |
| 10 | Cooper Companies | 10.51 Bn | 10.37 Bn | 735.40 Mn | 138.80 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Apr 30, 2026 | 138.80 Mn |
| Jan 31, 2026 | 124.90 Mn |
| Oct 31, 2025 | 110.60 Mn |
| Jul 31, 2025 | 124.90 Mn |
| Apr 30, 2025 | 116.20 Mn |
| Jan 31, 2025 | 100.90 Mn |
| Oct 31, 2024 | 107.60 Mn |
| Jul 31, 2024 | 109.70 Mn |
| Apr 30, 2024 | 112.40 Mn |
| Jan 31, 2024 | 135.20 Mn |
| Oct 31, 2023 | 120.80 Mn |
| Jul 31, 2023 | 117.30 Mn |
| Apr 30, 2023 | 111.90 Mn |
| Jan 31, 2023 | 118.20 Mn |
| Oct 31, 2022 | 138.20 Mn |
| Jul 31, 2022 | 246.30 Mn |
| Apr 30, 2022 | 399.20 Mn |
| Jan 31, 2022 | 280.70 Mn |
| Oct 31, 2021 | 95.90 Mn |
| Jul 31, 2021 | 112.20 Mn |